|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Ƥ������� |
|
Ƥ������ |
|
�ٷ��ͳ�����Ӧ |
| ��������������� | |
|
������ |
|
����� |
| PubMed | |
|
Article by WANG Ming-yue |
|
Article by LI Ruo-yu |
Ƥ�������Ⱦ�е�����Ӧ��
������, �����
������ѧ��һҽԺƤ���� 100034
���ڸ���������֪��ԭ��,�������߹��ܵ��µĻ��߲�������,�����Ⱦ����������,����������������������ѧ�о��������������Ⱦ����Բ�ͬ��Ƥ�������Ⱦ,���ַ�Ƥ���������ԭ�Ժͻ���Բ�ԭ�������Ӧ����Խ���,��������֬����Ƥ����Ӧ��Ƥ���������Ⱦ�Ĺ�ϵ��
Immune Responses to Cutaneous Fungal Infections
Department of Dermatology, Research Center for Medical Mycology, Peking University First Hospital, Beijing 100034, China
Department of Dermatology, Research Center for Medical Mycology, Peking University First Hospital, Beijing 100034, China
Due to the increase of malignancies, autoimmune diseases, transplantations, diabetes mellitus and HIV infections, the number of both immunocompromised patients and fungal infections rises to a new level. However, most of the immunologic studies in these fungal infections are restricted to deep mycoses. We review the immunologic studies in various skin fungal infections and summarize the functions of major cells and molecules involved in the immune responses to the fungi invading the skin. Fungal antigenicities and immune responses are described for different cutaneous infection types. Additionally, the relationship between some fungi related diseases, such as seborrhoeic dermatitis as well as atopic dermatitis, and fungal infections is also reviewed.
[2] Fradin C,Poulain D,Jouault T.beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3.Infect Immun,2000,68:4391-4398.
[3] Lilic D,Gravenor I,Robson N,et al.Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis.Infect Immun,2003,71:5690-5699.
[4] Noverr MC,Toews GB,Huffnagle GB.Production ofprostaglandins and leukotrienes by pathogenic fungi.Infect Immun,2002,70:400-402.
[5] Han Y,Riesselman MH,Cutler JE.Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody.Infect Immun,2000,68:1649-1654.
[6] Kozel TR,MacGill RS,Percival A,et al.Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.Infect Immun,2004,72:209-218.
[7] Tang N,Liu L,Kang K,et al.Inhibition of monocytic interleukin-12production by Candida albicans via selective activation of ERK mitogen-activated protein kinase.Infect Immun,2004,72:2513-2520.
[8] Nir-Paz R,Elinav H,Pierard GE,et al.Deep infection by Trichophyton rubrum in an immunocompromised patient.J Clin Microbiol,2003,41:5298-5301.
[9] Woodfolk JA,Sung SS,Benjamin DC,et al.Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen,Tri r 2.J Immunol,2000,165:4379-4387.
[10] Kawamoto S,Yalcindag A,Laouini D,et al.The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.J Clin Invest,2004,114:399-407.
[11] Suzuki T,Tsuzuki A,Ohno N,et al.Enhancement of IL-8 production from human monocytic and granulocytic cell lines,THP-1 and HL-60,stimulated with Malassezia furfur.FEMS Immunol Med Microbiol,2000,28:157-162.
[12] Kesavan S,Holland KT,Ingham E.The effects of lipid extraction on the immunomodulatory activity of Malassezia species in vitro.Med Mycol,2000,38:239-247.
[13] Saadatzadeh MR,Ashbee HR,Cunliffe WJ,et al.Cell-mediated immunity to the mycelial phase of Malassezia spp.in patients with pityriasis versicolor and controls.Br J Dermatol,2001,144:77-84.
[14] Savolainen J,Lintu P,Kosonen J,et al.Pityrosporum and Candida specific and non-specific humoral,cellular and cytokine responses in atopic dermatitis patients.Clin Exp Allergy,2001,31:125-134.